SCHEMBL26098334

SCHEMBL26098334

COc1ccc(CN2CC(Oc3cc4ncnc(-c5ccc(NC(=O)Cc6ccc(C(F)(F)F)cc6)cc5)c4cc3OC)C2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 3/20 0.50
▸ ERBB2 P04626 2/20 0.50
▸ KDR P35968 7/20 0.48
▸ PDGFRB P09619 8/20 0.46
▸ CSF1R P07333 4/20 0.46
▸ KIT P10721 2/20 0.46
▸ RET P07949 1/20 0.46
▸ PDGFRA P16234 1/20 0.46
▸ DDR1 Q08345 1/20 0.46
▸ FLT4 P35916 9/20 0.46
▸ FLT3 P36888 6/20 0.46
▸ BRAF P15056 2/20 0.44
▸ FLT1 P17948 2/20 0.44
▸ CYP2C9 P11712 1/20 0.43
▸ MAPK14 Q16539 1/20 0.42
▸ TNNI3K Q59H18 1/20 0.42
▸ PRKAB2 O43741 1/20 0.42
▸ PRKAG1 P54619 1/20 0.42
▸ PRKAA2 P54646 1/20 0.42
▸ PRKAA1 Q13131 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30393114 1.00 EGFR (0.50) EGFRERBB2KDRPDGFRBCSF1R
SCHEMBL26536031 0.92 EGFR (0.52) EGFRERBB2KDRPDGFRBCSF1R
SCHEMBL30394681 0.92 EGFR (0.52) EGFRERBB2KDRPDGFRBCSF1R
SCHEMBL30393989 0.90 EGFR (0.50) EGFRERBB2KDRPDGFRBCSF1R
SCHEMBL26102970 0.90 EGFR (0.50) EGFRERBB2KDRPDGFRBCSF1R
SCHEMBL26100120 0.89 EGFR (0.55) EGFRERBB2KDRPDGFRBCSF1R
SCHEMBL26136013 0.88 EGFR (0.53) EGFRERBB2KDRPDGFRBKIT
SCHEMBL30394387 0.88 EGFR (0.53) EGFRERBB2KDRPDGFRBKIT
SCHEMBL30393135 0.87 EGFR (0.48) EGFRERBB2KDRPDGFRBCSF1R
SCHEMBL26132918 0.87 EGFR (0.48) EGFRERBB2KDRPDGFRBCSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118201909-A Quinazoline derivative compound and use thereof 株式会社沃若诺伊 2024-06-14 — — CN claimed
WO-2023075529-A1 QUINAZOLINE DERIVATIVE COMPOUND AND USE THEREOF 보로노이바이오 주식회사 2023-05-04 — — WO disclosed
WO-2023075529-A1 QUINAZOLINE DERIVATIVE COMPOUND AND USE THEREOF 보로노이바이오 주식회사 2023-05-04 — — WO disclosed
Send feedback